Action NVS NOVARTIS AG
Ajouter à une liste

Connexions Novartis AG NYSE

Actions

NVS

US66987V1098

Produits pharmaceutiques

Temps réel estimé
Cboe BZX
19:15:50 27/08/2026 		Varia. 5j. Varia. 1 janv.
154,70 USD -1,81% Graphique intraday de Novartis AG -1,00% +12,19%
18:16 Bourse Zurich: les indices finissent en rouge avant Jackson Hole AW
08:46 Bourse Zurich: optimisme attendu à l'ouverture AW

46

Sociétés cotées

50

Entreprise privées

483

Insiders

Graphique Relationnel des Sociétés Cotées liées: Novartis AG

Relations Actives

Relations Passées

Sociétés Cotées liées: Novartis AG

PHILIPS NV
Liz Doherty Doherty
STRYKER CORPORATION
Giovanni Caforio
WATERS CORPORATION
Flemming Ørnskov
Udit Batra
Amol Chaubal
BIOGEN INC.
Ginger Gregory
Adam Feire
STMICROELECTRONICS N.V.
Ana de Pro Gonzalo
METTLER-TOLEDO INTERNATIONAL, INC.
Ingrid Zhang
PHIBRO ANIMAL HEALTH CORPORATION
Judith Weinstein
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Nancy Andrews
MONDELEZ INTERNATIONAL, INC.
Dirk Van de Put
Brian McNamara
LEXICON PHARMACEUTICALS, INC.
Michael Exton
OBERSTDORFER BERGBAHN AG
Steffen Lang
MILESTONE PHARMACEUTICALS INC.
Joseph Papa
Guy Rousseau
AURA BIOSCIENCES, INC.
Antony Mattessich
Janet Hopkins
LONZA GROUP AG
Juan Andres
Maria Nunez
Nicoleta Baumgärtner
CORBION N.V.
Liz Doherty Doherty
SCHINDLER HOLDING AG
Patrice Bula
MOBICO GROUP PLC
Ana de Pro Gonzalo
GEORG FISCHER AG
Ton Büchner
SWISS PRIME SITE AG
Ton Büchner
BACHEM HOLDING AG
Steffen Lang
SOFTING AG
Matthias Weber
REVENIO GROUP OYJ
Riad Sherif
BIOMÉRIEUX
Viviane Monges
DEXCOM, INC.
Bridgette Heller
DKSH HOLDING AG
Marco Gadola
DBV TECHNOLOGIES
Pascal Wotling
Monde
Bridgette Heller
MOLECULAR PARTNERS AG
Michael Pitzner
BIONTECH SE
Susanne Antonie Schaffert
Sierk Poetting
MEDARTIS HOLDING AG
Marco Gadola
ADC THERAPEUTICS SA
Ameet Mallik
Jose Carmona
Viviane Monges
CANDEL THERAPEUTICS, INC.
Joseph Papa
Nicoletta Loggia
Seshu Tyagarajan
BIOTALYS NV
Simon Moroney
AURINIA PHARMACEUTICALS INC.
Jeffrey Bailey
Kathy Goetz
BEIGENE LTD
Charles Sawyers
Alessandro Riva
Giancarlo Benelli
PHARVARIS N.V.
Viviane Monges
ABSCI CORPORATION
Frans van Houten
JOHNSON CONTROLS INTERNATIONAL PLC
John Young
MODERNA, INC.
Shannon Klinger
Jerh Collins
Monde
Nancy Andrews
AGOMAB THERAPEUTICS NV
David Epstein
Angelika Jahreis
NRX PHARMACEUTICALS, INC.
Rick Panicucci
RALLYBIO CORPORATION
Liu Hui
OCULIS HOLDING AG
Riad Sherif
Rebecca Weil
NORDICUS PARTNERS CORPORATION
Peter Severin
SANDOZ GROUP AG
Karen Hübscher
Elizabeth Theophille

Relations Actives

Relations Passées

Graphique Relationnel des Sociétés Privées liées: Novartis AG

Relations Actives

Relations Passées

Entreprise Privées liées: Novartis AG

Novartis International AG

Pharmaceuticals: Major

Hans Jörg Reinhardt
Shannon Klinger
Nancy Andrews
Harry Werner Kirsch
Vasant Narasimhan
Biotechnology Innovation Organization

Miscellaneous Commercial Services

David Pyott
Pablo Cagnoni
Deborah Dunsire
Flemming Ørnskov
Charl van Zyl
Ludwig Hantson
Meenu Chhabra Karson
Royston Glasspool
Serica Technologies, Inc.

Pharmaceuticals: Major

F. Ball
David Pyott
abrdn Life Sciences Investors

Investment Trusts/Mutual Funds

Jeffrey Bailey
Kathy Goetz
abrdn Healthcare Opportunities Fund

Investment Trusts/Mutual Funds

Jeffrey Bailey
Kathy Goetz
abrdn World Healthcare Fund

Investment Trusts/Mutual Funds

Jeffrey Bailey
Kathy Goetz
STADA Arzneimittel AG

Pharmaceuticals: Generic

Eric Cornut
Miguel Fernandez
Novo Holdings A/S (Denmark)

Investment Managers

Susanne Antonie Schaffert
Viviane Monges
Institute of Chartered Accountants in England & Wales

Miscellaneous Commercial Services

Jonathan Symonds
John McAdoo
The General Hospital Corp.

Hospital/Nursing Management

Mark Fishman
Mason W. Freeman
Atlas Venture Advisors, Inc.

Investment Managers

Jeffrey Hrkach
Vic Myer
Northwestern University

Other Consumer Services

Bridgette Heller
Elizabeth McNally
University of St. Gallen

Other Consumer Services

Thomas Werlen
Ruth Metzler-Arnold
American Bar Association

Miscellaneous Commercial Services

Shannon Klinger
Diane E. Sugrue
Novartis Pharmaceuticals Corp.

Pharmaceuticals: Major

Hans Jörg Reinhardt
Thomas N. Kendris
Vasant Narasimhan
Mukul Mehta
University of Basel

Other Consumer Services

Paul Herrling
Jutta Monika Heim
John Martin Manser
Verena A. Briner
Speedel Pharma AG

Pharmaceuticals: Major

Thomas Littke
Peter Herold
National Academy of Sciences

Miscellaneous Commercial Services

William J. Rutter
Charles Sawyers
Nancy Andrews
American Academy of Arts & Sciences

Miscellaneous Commercial Services

Ann Marie Fudge
William J. Rutter
Charles Sawyers
National Academy of Medicine (United States)

Miscellaneous Commercial Services

William Brody
Charles Sawyers
Nancy Andrews
Vasant Narasimhan
The District of Columbia Bar

Miscellaneous Commercial Services

Shannon Klinger
Theresa Maria Stevens
European Federation of Pharmaceutical Industries & Assns

Miscellaneous Commercial Services

Kim Stratton
Giovanni Caforio
Patrick Horber
Massachusetts Biotechnology Council

Miscellaneous Commercial Services

Abbie Celniker
Udit Batra
Novartis Institutes for Biomedical Research, Inc.

Miscellaneous Commercial Services

Hans Jörg Reinhardt
Harry Werner Kirsch
Novartis Pharma AG

Pharmaceuticals: Major

Hans Jörg Reinhardt
Vasant Narasimhan
Shreeram Aradhye
Teresa Jose
Harvard Medical School

Other Consumer Services

Mason W. Freeman
Nancy Andrews
Vasant Narasimhan
Waters Technologies Corp.

Medical Specialties

Udit Batra
Amol Chaubal
E. Merck KG

Pharmaceuticals: Major

Susanne Antonie Schaffert
André Wyss
IMD Scholarship Foundation

Karen Hübscher
Marie-France Tschudin
SIX Swiss Exchange AG

Investment Banks/Brokers

Thomas Werlen
Andreas von Planta
Novartis Pharma KK

Pharmaceuticals: Major

Harry Werner Kirsch
Paul Hudson
Novartis Pharma BV

Hans Jörg Reinhardt
Vasant Narasimhan
Swiss Bar Association

Felix R. Ehrat
Laurent Sigismondi
Zurich Bar Association

Felix R. Ehrat
Daniel Hochstrasser
The Consumer Goods Forum

Miscellaneous Commercial Services

Dirk Van de Put
Brian McNamara
Association of the European Self-Medication Industry

Brian McNamara
Udit Batra
Affidea BV

Medical/Nursing Services

Stefan Mario Meister
Frans van Houten
Galderma Holding SA

Pharmaceuticals: Major

Thomas Ebeling
Flemming Ørnskov
Vasomune Therapeutics, Inc.

Pharmaceuticals: Other

Meenu Chhabra Karson
Meenu Karson
Fore Biotherapeutics, Inc.

Pharmaceuticals: Major

Meenu Chhabra Karson
Meenu Karson
Novartis Foundation

Miscellaneous Commercial Services

Hans Jörg Reinhardt
Andreas von Planta
Vasant Narasimhan
Lutz Hegemann
Tango Therapeutics Sub, Inc.

Biotechnology

Barbara Weber
Malte Peters
Aberdeen Investments LLC

Financial Conglomerates

Jeffrey Bailey
Kathy Goetz
CIBA Vision GmbH (Germany)

Electronic Components

Felix R. Ehrat
Susanne Antonie Schaffert
ImmunOs Therapeutics AG

Biotechnology

Daniel Vasella
Reinhard Ambros
Ring Therapeutics, Inc.

Pharmaceuticals: Major

David Epstein
Juan Andres
Medartis AG

Marco Gadola
Anthony Durieux-Menage
Valo Health LLC

Packaged Software

David Epstein
Shreeram Aradhye
Abata Therapeutics, Inc.

Biotechnology

Abbie Celniker
Nagesh Mahanthappa
Anteris Bio, Inc.

Pharmaceuticals: Major

Joseph Jimenez
Mark Fishman

Relations Actives

Relations Passées

Statistiques des Connexions

Actives

Inactives

Sociétés cotées

Entreprise privées

Activités des Sociétés liées

Pharmaceuticals: Major22
Miscellaneous Commercial Services14
Biotechnology14
Medical Specialties8
Other Consumer Services4
Investment Trusts/Mutual Funds3
Industrial Machinery3
Medical/Nursing Services2
Food: Specialty/Candy2
Other Transportation2

Pays des Sociétés liées

Etats-Unis43
Suisse26
Allemagne6
Pays-Bas5
Belgique4
France3
Canada3
Royaume-Uni2
Japon1
Danemark1

Profil Société

Logo Novartis AG
Novartis AG figure parmi les leaders mondiaux de la conception, de la fabrication et de la commercialisation de produits pharmaceutiques. Le CA par domaine thérapeutique se répartit comme suit : - oncologie (30,9%) ; - immunologie (18,9%) ; - maladies cardio-vasculaires, rénales et métaboliques (16,4%) ; - neuroscience (11%) ; Le solde du CA (22,8%) concerne l'activité de fabrication en sous-traitance de produits pharmaceutiques. A fin 2025, Novartis AG dispose de plus de 31 sites de production dans le monde. La répartition géographique du CA est la suivante : Suisse (2,6%), Europe (28,1%), Etats-Unis (42,8%), Asie-Afrique-Australasie (19,8%), Canada et Amérique latine (6,7%).
Employés
75 267
Secteur
Produits pharmaceutiques
Agenda
27/10 Publication des résultats - Q3 2026
Plus d'informations sur la société
  1. Bourse
  2. Actions
  3. Action NOVN
  4. Action NVS
  5. Société Novartis AG
  6. Connexions

Sélectionnez votre édition

Toutes les informations financières adaptées au niveau national

NORTH AMERICA

MarketScreener
United-States
MarketScreener Canada
Canada

MIDDLE EAST

MarketScreener Saudi Arabia
Saudi Arabia
MarketScreener UAE Emirates
United Arab Emirates

EUROPE

Zonebourse
France
MarketScreener Deutschland
Deutschland
Zonebourse Suisse
Suisse
MarketScreener Schweiz
Schweiz
MarketScreener Italia
Italia
MarketScreener Österreich
Österreich
MarketScreener België
België
MarketScreener Nederland
Nederland
MarketScreener España
España
MarketScreener Sverige
Sverige
MarketScreener UK
United Kingdom

APAC

MarketScreener Australia
Australia
MarketScreener India
India
MarketScreener Hong Kong
Hong Kong